Diseases [C] » Chemically-Induced Disorders [C25] » Substance-Related Disorders » Narcotic-Related Disorders » Opioid-Related Disorders
Psychiatry and Psychology [F] » Mental Disorders [F03] » Substance-Related Disorders » Narcotic-Related Disorders » Opioid-Related Disorders
Hierarchy View
Subtype Terms (4)
Heroin Dependence
29 drugs (24 approved, 5 experimental)
Morphine Dependence
3 approved drugs
Opiate Overdose
8 drugs (7 approved, 1 experimental)
Phase 4 Indicated Drugs (35)
Phase 3 Indicated Drugs (16)
Phase 2 Indicated Drugs (45)
Other Experimental Indicated Drugs (9)
Organization Involved with Phase 4 Indications (77)
Canadian Research Initiative in Substance Misuse
Community Research Initiative of New England
Drug Treatment Court, Wake County, NC
El Rio Santa Cruz Neighborhood Health Center
Friends Research Institute, Inc.
Icahn School of Medicine at Mount Sinai
Laura and John Arnold Foundation
Member Companies of the Opioid PMR Consortium
National Cancer Institute (NCI)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
National Institute on Drug Abuse (NIDA)
Oregon Health and Science University
State University of New York, Buffalo
The New York Academy of Medicine
Universidade Federal de Alfenas
University of Alabama, Birmingham
University of British Columbia
University of California, Los Angeles
Organization Involved with Phase 3 Indications (61)
Bekhterev Psychoneurological Research Institute
BioDelivery Sciences International
Britannia Pharmaceuticals Ltd.
Canadian Institutes of Health Research (CIHR)
Hoosier Cancer Research Network
Kazan State Medical University
Leningrad Addiction Treatment & Research Center
Mountain Manor Treatment Center, Baltimore MD
National Cheng Kung University
National Institute of Allergy and Infectious Diseases (NIAID)
New York City Department of Health and Mental Hygiene
Pavlov First Saint Petersburg State Medical University
Reckitt Benckiser Pharmaceutical
Research Foundation for Mental Hygiene, Inc.
Russian Academy of Medical Sciences
Saint-Petersburg State Medical University
Organization Involved with Phase 2 Indications (62)
Ambulanz fur integrierte Drogenhilfe
Beijing ziduhongye technology development co. LTD
International Center for Ethnobotanical Education, Research, and Service
Medical University of South Carolina
Multidisciplinary Association for Psychedelic Studies
National Development and Research Institutes, Inc.
People's Liberation Army of China
St. Luke's-Roosevelt Hospital Center
Substitutionsambulanz Geinhausen
The University of Texas, Dallas
Universidad Autonoma de Madrid
University of Colorado, Denver
Organization Involved with Phase 1 Indications (16)
Organization Involved with Other Experimental Indications (6)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
